Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2
Roger G. Pertwee, A­llyn C. Howlett, Mary E. Abood, et al.
Pharmacological Reviews (2010) Vol. 62, Iss. 4, pp. 588-631
Open Access | Times Cited: 1528

Showing 1-25 of 1528 citing articles:

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo, Thomas J. Younts, Andrés E. Chávez, et al.
Neuron (2012) Vol. 76, Iss. 1, pp. 70-81
Open Access | Times Cited: 1008
The Endocannabinoid System and the Brain
Raphael Mechoulam, Linda A. Parker
Annual Review of Psychology (2012) Vol. 64, Iss. 1, pp. 21-47
Closed Access | Times Cited: 989
Phytocannabinoids: a unified critical inventory
L Hanŭs, Stefan Meyer, Eduardo Muñóz, et al.
Natural Product Reports (2016) Vol. 33, Iss. 12, pp. 1357-1392
Open Access | Times Cited: 734
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone, Itai Bab, Tamás Bı́ró, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 5, pp. 277-296
Open Access | Times Cited: 595
Multiple Functions of Endocannabinoid Signaling in the Brain
István Katona, Tamás F. Freund
Annual Review of Neuroscience (2012) Vol. 35, Iss. 1, pp. 529-558
Open Access | Times Cited: 556
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
GPCR-Mediated Signaling of Metabolites
Anna Sofie Husted, Mette Trauelsen, Olga Rudenko, et al.
Cell Metabolism (2017) Vol. 25, Iss. 4, pp. 777-796
Open Access | Times Cited: 500
Cannabis, a complex plant: different compounds and different effects on individuals
Zerrin Atakan
Therapeutic Advances in Psychopharmacology (2012) Vol. 2, Iss. 6, pp. 241-254
Open Access | Times Cited: 483
Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland, Marnie Duncan, Vincenzo Di Marzo, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 3, pp. 737-753
Open Access | Times Cited: 473
Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Maren Hermanns‐Clausen, Stefan Kneisel, Béla Szabó, et al.
Addiction (2012) Vol. 108, Iss. 3, pp. 534-544
Closed Access | Times Cited: 468
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 39, Iss. 2, pp. 234-243
Open Access | Times Cited: 455
Molecular Targets of the Phytocannabinoids: A Complex Picture
Paula Morales, Dow P. Hurst, Patricia H. Reggio
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2017), pp. 103-131
Open Access | Times Cited: 419
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 412
The Pharmacologic and Clinical Effects of Medical Cannabis
Laura M. Borgelt, Kari L. Franson, Abraham M. Nussbaum, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2013) Vol. 33, Iss. 2, pp. 195-209
Open Access | Times Cited: 405
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pál Pacher, Raphael Mechoulam
Progress in Lipid Research (2011) Vol. 50, Iss. 2, pp. 193-211
Open Access | Times Cited: 402
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.
Mary Barna Bridgeman, Daniel T. Abazia
PubMed (2017) Vol. 42, Iss. 3, pp. 180-188
Closed Access | Times Cited: 390
Plant derived substances with anti-cancer activity: from folklore to practice
Marcelo Fridlender, Yoram Kapulnik, Hinanit Koltai
Frontiers in Plant Science (2015) Vol. 6
Open Access | Times Cited: 380
Modulating the endocannabinoid system in human health and disease – successes and failures
Pál Pacher, George Kunos
FEBS Journal (2013) Vol. 280, Iss. 9, pp. 1918-1943
Open Access | Times Cited: 369
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pál Pacher, Sabine Steffens, György Haskó, et al.
Nature Reviews Cardiology (2017) Vol. 15, Iss. 3, pp. 151-166
Closed Access | Times Cited: 358
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
Serena Deiana, Akihito Watanabe, Yuki Yamasaki, et al.
Psychopharmacology (2011) Vol. 219, Iss. 3, pp. 859-873
Closed Access | Times Cited: 354
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco, Cristina Sánchez, Manuel Guzmán
Nature reviews. Cancer (2012) Vol. 12, Iss. 6, pp. 436-444
Closed Access | Times Cited: 348
Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines
Christopher D. Rosenbaum, Stephanie Carreiro, Kavita M. Babu
Journal of Medical Toxicology (2012) Vol. 8, Iss. 1, pp. 15-32
Open Access | Times Cited: 348
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam, L Hanŭs, Roger G. Pertwee, et al.
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 757-764
Closed Access | Times Cited: 345
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Javier Fernández‐Ruíz, Onintza Sagredo, M. Ruth Pazos, et al.
British Journal of Clinical Pharmacology (2012) Vol. 75, Iss. 2, pp. 323-333
Open Access | Times Cited: 327
Page 1 - Next Page

Scroll to top